New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies (Q31122605)

29 June 2017

New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies (English)

1 reference

29 June 2017

Hervé Husson

1

1 reference

29 June 2017

Partha Manavalan

2

1 reference

29 June 2017

Viatcheslav R Akmaev

3

1 reference

29 June 2017

Ryan J Russo

4

1 reference

29 June 2017

Brian Cook

5

1 reference

29 June 2017

Brenda Richards

6

1 reference

29 June 2017

Dana Barberio

7

1 reference

29 June 2017

Dongyu Liu

8

1 reference

29 June 2017

Xiaohong Cao

9

1 reference

29 June 2017

Gregory M Landes

10

1 reference

29 June 2017

Clarence J Wang

11

1 reference

29 June 2017

Bruce L Roberts

12

1 reference

29 June 2017

Katherine W Klinger

13

1 reference

29 June 2017

Shelley A Grubman

14

1 reference

29 June 2017

Douglas M Jefferson

15

1 reference

29 June 2017

Oxana Ibraghimov-Beskrovnaya

16

1 reference

29 June 2017

1 September 2004

1 reference

29 June 2017

1 reference

29 June 2017

84

1 reference

29 June 2017

3

1 reference

29 June 2017

497-510

1 reference

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

29 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal cystic disease. Insights from recent experimental investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Angiogenesis in autosomal-dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystic kidney disease: primary extracellular matrix abnormality or defective cellular differentiation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Cyst-derived cells do not exhibit accelerated growth or features of transformed cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autosomal-dominant polycystic kidney disease in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

CT in the evaluation of complicated autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Neutrophils and renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Flow cytometric immunodissection of the human nephron in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Inhibition of catalase and epoxide hydrolase by the renal cystogen 2-amino-4,5-diphenylthiazole and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Experimental design for gene expression microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Analysis of variance for gene expression microarray data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Interaction between RGS7 and polycystin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The polycystic kidney disease 1 gene product modulates Wnt signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Expression of differentiation antigens and growth-related genes in normal kidney, autosomal dominant polycystic kidney disease, and renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Autosomal dominant polycystic kidney disease--in vitro culture of cyst-lining epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Association of cyclosporin A with acquired cystic kidney disease of the native kidneys in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystic kidney disease: Etiology, pathogenesis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Inflammatory cytokine profile in autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Matrix metalloproteinases in tumor invasion: role for cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Molecular characteristics of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal infections in autosomal dominant polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal cysts in polycystic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

New insights into polycystic kidney disease and its treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Serial analysis of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Design issues for cDNA microarray experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

Gene expression profiles in normal and cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGENO.2004.03.009

10.1016/J.YGENO.2004.03.009

7 January 2021

Identifiers

DOI

1 reference

29 June 2017

1 reference